Valuation
- Market cap
- 26,673,000
- Revenue TTM
- $1,140,000
- Net income TTM
- $-10,470,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -918.42%
- Debt to equity
- 0.00
Trading
- Volume
- 8,008
- Avg volume
- 13,526
- Day's range
- $0.62 – $0.69
- Shares out
- 38,105,000
- Stochastic %K
- 54%
- Beta
- 1.33
- Analysts
- Strong Buy
- Price target
- $7.00
Company profile
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human...
Show more
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. The company is based in Edina, Minnesota.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 952 405 6216
- Website
- https://www.petvivo.com
- Address
- 5151 Edina Industrial Boulevard, Suite 575, Edina, United States
Latest news
No headlines yet.
